In recent study, 23 percent of NHANES primary prevention cohort currently using lipid-lowering therapies versus 47 percent eligible under U.S. guidelines.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subject in the YOSEMITE Phase 3 clinical trial of zodasiran, the company’s investigational RNA interference ...

Heart disease is often seen as a problem that only affects older adults, but more and more young people are being diagnosed ...

The placebo-controlled study is aimed at assessing the safety and efficacy of zodasiran in adults and adolescents with HoFH.

Do you have high cholesterol? You're not alone — millions of adults in the United States face this common but serious issue. High cholesterol increases the risk of heart disease, ...

What to Know About Managing Familial Hypercholesterolemia — A multipronged approach is needed for these patients to achieve adequate cholesterol lowering ...

The firm is hoping to show that the RNAi drug can treat HoFH by reducing production of ANGPTL3, which regulates lipid and lipoprotein metabolism.

Eli Lilly & Co. has divulged relaxin receptor 1 (RXFP1; LGR7) agonists reported to be useful for the treatment of diabetes, stroke, atherosclerosis, pulmonary hypertension, chronic obstructive ...

Margie Junker, an expert in cardiovascular nutrition, has shared seven foods she eats for a healthy heart, as well as some ...

An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific ...

High cholesterol can be reduced by eating certain foods. A British Heart Foundation cardiologist has shared the two foods ...

Switching what’s on your plate might change your cholesterol faster than you think—here’s what the latest research and ...